Franco Cavalli
Cavalli, Francesco.
Cavalli, Franco
Cavalli, Franco 1942-....
Cavalli, F.
Cavalli, Francesco (medycyna).
VIAF ID: 250794246 (Personal)
Permalink: http://viaf.org/viaf/250794246
Preferred Forms
- 200 _ | ‡a Cavalli ‡b Franco ‡f 1942-....
-
- 100 1 _ ‡a Cavalli, Francesco
-
-
- 100 1 _ ‡a Cavalli, Francesco
-
-
- 100 1 _ ‡a Cavalli, Franco
-
-
- 100 1 _ ‡a Cavalli, Franco ‡d 1942-
- 100 1 _ ‡a Cavalli, Franco ‡d 1942-
- 100 1 _ ‡a Cavalli, Franco ‡d 1942-
- 100 0 _ ‡a Franco Cavalli
4xx's: Alternate Name Forms (22)
5xx's: Related Names (1)
- 551 _ _ ‡a Locarno ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
Title | Sources |
---|---|
Angst des Patienten, Angst des Arztes | |
Annual of lymphoid malignancies | |
Cancer, le grand défi les nouvelles victoires de la médecine | |
Endocrine therapy of breast cancer : concepts and strategies | |
Extranodal lymphomas : pathology and management | |
Krebs die große Herausforderung | |
L'Ercole. | |
Lymphoma and leukemia of the nervous system, (Springer) | |
Malignant lymphomas and Hodgkin's disease : experimental and therapeutic advances : proceedings of the Second International Conference on Malignant Lymphomas, Lugano, Switzerland, June 13-16, 1984 | |
Medien, Internet - Öffentlichkeit | |
Non-Hodgkin's lymphoma terminating in acute myelogenous leukemia | |
Novel high-dose chemotherapy strategies with and without progenitor cell support to improve survival in solid tumours and haematological malignancies, June 2-5, 1994, Brussels, November 18-22, 1994, Lisbon : selected papers | |
Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites | |
Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials | |
Proceedings of the International Symposium on Medroxyprogesterone Acetate Geneva, Switzerland, February 24-26, 1982 | |
Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland | |
[Prognostic factors in metastasizing melanoma] | |
Prognostic impact of monocyte count at presentation in mantle cell lymphoma. | |
[Progress in the chemotherapy of malignant tumors] | |
[Prolymphocytic leukaemia: a new clinical entity | |
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma. | |
Proposing phase I studies: patients', relatives', nurses' and specialists' perceptions | |
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients | |
Purloined pearls | |
Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group. | |
[Randomized phase II study with VP-16-213 (etoposide) in the treatment of advanced breast cancer] | |
Rare syndromes in Hodgkin's disease | |
Relevance of intraocular involvement in the management of primary central nervous system lymphomas. | |
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al | |
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. | |
Report on the international workshop on staging and treatment of testicular cancer | |
[Results of a pilot study with high-dose medroxyprogesterone acetate in the treatment of metastasizing breast carcinoma] | |
Rime...composte nelle più oscure & fetide prigioni di Padova , heroiche, amorose, funebri, essemplari & sacre. Parte prima...In Padovaper Orlando Iadra, nella stampa del Pasquati. | |
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group | |
Serse | |
Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76 | |
Short report: Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma | |
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more | |
Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases | |
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer] | |
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group | |
[Supradiaphragmatic right-sided space-occupying lesion] | |
Tackling cancer: time for a global response | |
Tamoxifen in advanced breast cancer: experience of the SAKK (Schweizerische Arbeitsgruppe für Klinische Krebsforschung--Swiss Cooperative Oncology Group) | |
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group | |
Text atlas of lymphomas | |
Textbook of Medical Oncology | |
Therapeutic results and prognostic factors in acute lymphatic leukemia in the adult | |
Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab | |
Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma | |
Treatment and prognosis of centrocytic | |
Treatment for patients with indolent and mantle cell lymphoma | |
The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination | |
Treatment of childhood Hodgkin's disease with COPP or COPP-ABV | |
Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua | |
Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua | |
Update on the molecular biology of mantle cell lymphoma | |
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions | |
Vincristine overdose: treatment with and without leucovorin rescue | |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma] | |
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules | |
VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research | |
VP16-213 (etoposide). A critical review of its activity | |
Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphoma | |
What has prevented Annals of Oncology from reaching an impact factor of 6? | |
Which staging for malignant lymphomas? | |
Who benefits from phase I studies? | |
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extran | |
The World Cancer Declaration: a roadmap for change |